The University of Chicago Header Logo

Connection

Richard A. Larson to Antibiotics, Antineoplastic

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Antibiotics, Antineoplastic.
Richard A. Larson
Connection Strength
0.175
Antibiotics, Antineoplastic
  1. Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia. Clin Cancer Res. 2008 Nov 01; 14(21):7095-101.
    View in: PubMed
    Score: 0.080
  2. Current use and future development of gemtuzumab ozogamicin. Semin Hematol. 2001 Jul; 38(3 Suppl 6):24-31.
    View in: PubMed
    Score: 0.048
  3. New agents for induction and postremission therapy of acute myeloid leukemia. Leukemia. 2001 Apr; 15(4):675-6.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.